Karen Waetjen


Karen Waetjen is director, GCP/GLP Compliance, Amgen.


Collaborative Efforts Address Key Data Integrity Challenges

Maintaining a quality culture across the diverse functions in a bio/pharmaceutical company is difficult. Representatives of the Quality Coordinating Committee of IQ Consortium report on collaborative efforts to address data integrity and the modernization of FDA’s good laboratory practice regulations.